Twenty-Five Years of Cancer Research: Stunning Breakthroughs and Sobering Setbacks
Marking the 25th anniversary of Nature Reviews Cancer, six leading researchers assess the transformative advances and unfulfilled expectations of a ...
Marking the 25th anniversary of Nature Reviews Cancer, six leading researchers assess the transformative advances and unfulfilled expectations of a ...
Researchers are using PD-L1-targeted PET/CT imaging to directly visualise whether the immunotherapy drug atezolizumab saturates its target in tumours, offering ...
Preoperative urinary metabolites may improve survival prediction in colorectal cancer beyond tumor stage, according to a ColoCare study that identified ...
A new review details how artificial intelligence is being woven into every stage of personalized neoantigen cancer vaccine development, from ...
A new review synthesizes decades of evidence showing that selective COX-2 inhibitors can suppress tumor initiation, growth and immunotherapy resistance ...
The China Anti-Cancer Association's 2025 guidelines establish a comprehensive, multidimensional framework for assessing the whole cancer patient before and throughout ...
Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies in modern oncology, with five-year survival rates that have barely ...
A comprehensive review finds that patient-derived tumor organoid co-culture with immune cells offers the most physiologically faithful platform yet for ...
For nearly four decades, KRAS occupied a paradoxical position in cancer biology: it was the most intensively studied oncogene in ...
Cholangiocarcinoma, a cancer arising in the bile ducts, has become an unexpected test of whether precision oncology can deliver on ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine